Mixed cryoglobulinemia: new concepts (Q33901848)

29 July 2017

1 reference

title

Mixed cryoglobulinemia: new concepts (English)

1 reference

29 July 2017

Ricard Cervera i Segura

series ordinal

4

object named as

R Cervera

1 reference

29 July 2017

5

J Font

1 reference

29 July 2017

1

M Ramos-Casals

1 reference

29 July 2017

O Trejo

2

1 reference

PubMed ID

10787003

29 July 2017

M García-Carrasco

series ordinal

3

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

9

1 reference

29 July 2017

2

1 reference

29 July 2017

83-91

1 reference

Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability.

29 July 2017

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Biologic and clinical significance of cryoglobulins. A report of 86 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Cryoglobulinaemia and hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Hepatitis C virus infection in patients with essential mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Hepatitis C virus in patients with cryoglobulinemia type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Mixed cryoglobulinemia and hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Hepatitis C virus and mixed cryoglobulinaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Hepatitis C virus and cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

A role for hepatitis C virus infection in type II cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Reappraisal of the clinical expression of mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

GB virus C infection in patients with type II mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

HCV/HGV coinfection and cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Hepatitis G and mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Cryoglobulinemia in primary Sjögren's syndrome: prevalence and clinical characteristics in a series of 115 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Hepatitis C virus infection in 'primary' Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Specific concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Cryoglobulinemia and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Extrahepatic manifestations of HCV infection: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Hepatitis C virus infection in patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Viruses and cancers: possible role of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Monoclonal lymphocyte proliferation and bcl-2 rearrangement in essential mixed cryoglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Sjögren's syndrome and hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Secondary and Essential Cryoglobulinemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828127

10.1191/096120300678828127

21 January 2018

Identifiers

DOI

1 reference

release_rjn6h7kgungxfmhpgy4ncioi7a

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rjn6h7kgungxfmhpgy4ncioi7a

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

10787003

1 reference

PubMed ID

10787003